162.2. Symp. S34-2. Tue 16/07 09:30 - Salle Charcot
Mignot E.
Narcolepsy Ctr, Stanford University, Palo Alto, CA, USA
- HYPOCRETIN/OREXIN, SLEEP AND NARCOLEPSY.
162.3. Symp. S34-3. Tue 16/07 09:30 - Salle Charcot
Upton N.
Neurology CEDD, GSK, Harlow, UK
- ROLE OF THE OREXIN (HYPOCRETIN) LIGAND-RECEPTOR SYSTEM IN MODULATING AROUSAL AND BEHAVIOUR: AN INITIAL PHARMACOLOGICAL CHARACTERISATION.
162.4. Symp. S34-4. Tue 16/07 09:30 - Salle Charcot
Brown R. E. (1), Eriksson K. (2), Sergeeva O. A. (2), Korotkova T. M. (2) & Haas H. (2).
(1) Dept. Neurophys., Univ. Duesseldorf, Duesseldorf, Germany; (2) Dept. Neurophys., Duesseldorf, Germany.
- HYPOCRETINS/OREXINS AND AMINERGIC SYSTEMS.
162.5. Symp. S34-5. Tue 16/07 09:30 - Salle Charcot
Williams G. (1), Cai X. (1), Liu X. H. (1) & Morris R. (2)
(1) Diabetes & Endocrinology Research Group, Liverpool, UK; (2) Veterinary Preclinical Sciences Department, Liverpool, UK
- OREXINS AND FEEDING BEHAVIOUR: MISSING CLUE OR FALSE TRAIL.